<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li QR</submitter><funding>Cultivating Project for Young Scholar at Hubei University of Medicine</funding><funding>Innovative Research Program for Graduates of Hubei University of Medicine</funding><funding>National Training Program of Innovation and Entrepreneurship for Undergraduates</funding><funding>National Natural Science Foundation of China</funding><funding>Hubei Provincial Natural Science Foundation</funding><funding>Hubei Province health and family planning scientific research project</funding><pagination>937-949</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8956315</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(1)</volume><pubmed_abstract>The present work aims to prove the concept of tumor-targeted drug delivery mediated by platelets. Doxorubicin (DOX) attached to nanodiamonds (ND-DOX) was investigated as the model payload drug of platelets. In vitro experiments first showed that ND-DOX could be loaded in mouse platelets in a dose-dependent manner with a markedly higher efficiency and capacity than free DOX. ND-DOX-loaded platelets (Plt@ND-DOX) maintained viability and ND-DOX could be stably held in the platelets for at least 4 hr. Next, mouse Lewis lung cancer cells were found to activate Plt@ND-DOX and thereby stimulate cargo unloading of Plt@ND-DOX. The unloaded ND-DOX was taken up by co-cultured cancer cells which consequently exhibited loss of viability, proliferation suppression and apoptosis. In vivo, Plt@ND-DOX disp</pubmed_abstract><journal>Drug delivery</journal><pubmed_title>Platelets are highly efficient and efficacious carriers for tumor-targeted nano-drug delivery.</pubmed_title><pmcid>PMC8956315</pmcid><funding_grant_id>2019QDJZR02</funding_grant_id><funding_grant_id>202110929010</funding_grant_id><funding_grant_id>WJ2019Z010</funding_grant_id><funding_grant_id>2020QDJZR002</funding_grant_id><funding_grant_id>2020CFB152</funding_grant_id><funding_grant_id>YC2021016</funding_grant_id><funding_grant_id>81671818</funding_grant_id><funding_grant_id>202113249001</funding_grant_id><pubmed_authors>Li LG</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Han N</pubmed_authors><pubmed_authors>Xiao RC</pubmed_authors><pubmed_authors>Li TF</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Tang JM</pubmed_authors><pubmed_authors>Zhao L</pubmed_authors><pubmed_authors>Peng XC</pubmed_authors><pubmed_authors>Wang MF</pubmed_authors><pubmed_authors>Xu HZ</pubmed_authors><pubmed_authors>Komatsu N</pubmed_authors><pubmed_authors>Liu B</pubmed_authors><pubmed_authors>Li QR</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Yu TT</pubmed_authors><pubmed_authors>Xu YH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Platelets are highly efficient and efficacious carriers for tumor-targeted nano-drug delivery.</name><description>The present work aims to prove the concept of tumor-targeted drug delivery mediated by platelets. Doxorubicin (DOX) attached to nanodiamonds (ND-DOX) was investigated as the model payload drug of platelets. In vitro experiments first showed that ND-DOX could be loaded in mouse platelets in a dose-dependent manner with a markedly higher efficiency and capacity than free DOX. ND-DOX-loaded platelets (Plt@ND-DOX) maintained viability and ND-DOX could be stably held in the platelets for at least 4 hr. Next, mouse Lewis lung cancer cells were found to activate Plt@ND-DOX and thereby stimulate cargo unloading of Plt@ND-DOX. The unloaded ND-DOX was taken up by co-cultured cancer cells which consequently exhibited loss of viability, proliferation suppression and apoptosis. In vivo, Plt@ND-DOX disp</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-04T09:10:00.99Z</modification><creation>2025-04-04T09:10:00.99Z</creation></dates><accession>S-EPMC8956315</accession><cross_references><pubmed>35319321</pubmed><doi>10.1080/10717544.2022.2053762</doi></cross_references></HashMap>